Shionogi

4507.TSE

17.46 USD

0.09

+0.52%

Overview

Last close

17.46 usd

Market cap

14.85B usd

52 week high

18.38 usd

52 week low

12.04 usd

Target price

17.38 usd

Valuation

P/E

12.8864

Forward P/E

15.4083

Price/Sales

4.9847

Price/Book Value

1.5931

Enterprise Value

11.23B usd

EV/Revenue

3.773

EV/EBITDA

7.1673

Key financials

Revenue TTM

2.99B usd

Gross Profit TTM

2.57B usd

EBITDA TTM

1.25B usd

Earnings per Share

1.36 usd

Dividend

0.42 usd

Total assets

10.30B usd

Net debt

-2.37B usd

About

Shionogi & Co., Ltd. researches, develops, manufactures, and distributes pharmaceuticals, diagnostic reagents, and medical devices. It offers and develops drugs in the areas of infectious diseases, COVID-19, tumors, sclerosis, pomp, fragile X syndrome, and other diseases. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. Shionogi & Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan.